TY - JOUR T1 - Risk of DKA with SGLT2 inhibitors JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 69 LP - 69 DO - 10.1136/dtb.2021.000007 VL - 59 IS - 5 A2 - , Y1 - 2021/05/01 UR - http://dtb.bmj.com/content/59/5/69.abstract N2 - Overview of: Douros A, Lix LM, Fralick M, et al. Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis. Ann Intern Med 2020;173:417–25. ER -